Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Lisa Wang; Jan O Aasly; Grazia Annesi; Soraya Bardien; Maria Bozi; Alexis Brice; Jonathan Carr; Sun J Chung; Carl Clarke; David Crosiers; Angela Deutschländer; Gertrud Eckstein; Matthew J Farrer; Stefano Goldwurm; Gaetan Garraux; Georgios M Hadjigeorgiou; Andrew A Hicks; Nobutaka Hattori; Christine Klein; Beom Jeon; Yun J Kim; Suzanne Lesage; Juei-Jueng Lin; Timothy Lynch; Peter Lichtner; Anthony E Lang; Vincent Mok; Barbara Jasinska-Myga; George D Mellick; Karen E Morrison; Grzegorz Opala; Lasse Pihlstrøm; Peter P Pramstaller; Sung S Park; Aldo Quattrone; Ekaterina Rogaeva; Owen A Ross; Leonidas Stefanis; Joanne D Stockton; Peter A Silburn; Jessie Theuns; Eng K Tan; Hiroyuki Tomiyama; Mathias Toft; Christine Van Broeckhoven; Ryan J Uitti; Karin Wirdefeldt; Zbigniew Wszolek; Georgia Xiromerisiou; Kuo-Chu Yueh; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium

doi:10.1212/WNL.0000000000002016

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Lisa Wang, Jan O Aasly, Grazia Annesi, Soraya Bardien, Maria Bozi, Alexis Brice, Jonathan Carr, Sun J Chung, Carl Clarke, David Crosiers, Angela Deutschländer, Gertrud Eckstein, Matthew J Farrer, Stefano Goldwurm, Gaetan Garraux, Georgios M Hadjigeorgiou, Andrew A Hicks, Nobutaka Hattori, Christine Klein, Beom JeonYun J Kim, Suzanne Lesage, Juei-Jueng Lin, Timothy Lynch, Peter Lichtner, Anthony E Lang, Vincent Mok, Barbara Jasinska-Myga, George D Mellick, Karen E Morrison, Grzegorz Opala, Lasse Pihlstrøm, Peter P Pramstaller, Sung S Park, Aldo Quattrone, Ekaterina Rogaeva, Owen A Ross, Leonidas Stefanis, Joanne D Stockton, Peter A Silburn, Jessie Theuns, Eng K Tan, Hiroyuki Tomiyama, Mathias Toft, Christine Van Broeckhoven, Ryan J Uitti, Karin Wirdefeldt, Zbigniew Wszolek, Georgia Xiromerisiou, Kuo-Chu Yueh, Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium

Cancer and Genomic Sciences

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

213 Downloads (Pure)

Abstract

OBJECTIVES: We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).

METHODS: We invited researchers from the Genetic Epidemiology of Parkinson's Disease Consortium to participate in the study. There were 12,346 cases and 8,164 controls genotyped, for a total of 4 repeats within the SCA2, SCA3, SCA6, and SCA17 genes. Fixed- and random-effects models were used to estimate the summary risk estimates for the genes. We investigated between-study heterogeneity and heterogeneity between different ethnic populations.

RESULTS: We did not observe any definite pathogenic repeat expansions for SCA2, SCA3, SCA6, and SCA17 genes in patients with idiopathic PD from Caucasian and Asian populations. Furthermore, overall analysis did not reveal any significant association between intermediate repeats and PD. The effect estimates (odds ratio) ranged from 0.93 to 1.01 in the overall cohort for the SCA2, SCA3, SCA6, and SCA17 loci.

CONCLUSIONS: Our study did not support a major role for definite pathogenic repeat expansions in SCA2, SCA3, SCA6, and SCA17 genes for idiopathic PD. Thus, results of this large study do not support diagnostic screening of SCA2, SCA3, SCA6, and SCA17 gene repeats in the common idiopathic form of PD. Likewise, this largest multicentered study performed to date excludes the role of intermediate repeats of these genes as a risk factor for PD.

Original language	English
Pages (from-to)	1283-1292
Journal	Neurology
Volume	85
Early online date	9 Sept 2015
DOIs	https://doi.org/10.1212/WNL.0000000000002016
Publication status	Published - 13 Oct 2015

Bibliographical note

Access to Document

10.1212/WNL.0000000000002016

Wang_et_al_Large-scale_assessment_polyglutamine_Neurology_2015
Available after 12 month embargo in accordance with journal archiving policy 12/1/2016
Final published version, 435 KBLicence: None: All rights reserved

Cite this

Wang, L., Aasly, J. O., Annesi, G., Bardien, S., Bozi, M., Brice, A., Carr, J., Chung, S. J., Clarke, C., Crosiers, D., Deutschländer, A., Eckstein, G., Farrer, M. J., Goldwurm, S., Garraux, G., Hadjigeorgiou, G. M., Hicks, A. A., Hattori, N., Klein, C., ... Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium (2015). Large-scale assessment of polyglutamine repeat expansions in Parkinson disease. Neurology, 85, 1283-1292. https://doi.org/10.1212/WNL.0000000000002016

@article{41d2a29a09e1486bb6407932b691d8a8,

title = "Large-scale assessment of polyglutamine repeat expansions in Parkinson disease",

abstract = "OBJECTIVES: We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).METHODS: We invited researchers from the Genetic Epidemiology of Parkinson's Disease Consortium to participate in the study. There were 12,346 cases and 8,164 controls genotyped, for a total of 4 repeats within the SCA2, SCA3, SCA6, and SCA17 genes. Fixed- and random-effects models were used to estimate the summary risk estimates for the genes. We investigated between-study heterogeneity and heterogeneity between different ethnic populations.RESULTS: We did not observe any definite pathogenic repeat expansions for SCA2, SCA3, SCA6, and SCA17 genes in patients with idiopathic PD from Caucasian and Asian populations. Furthermore, overall analysis did not reveal any significant association between intermediate repeats and PD. The effect estimates (odds ratio) ranged from 0.93 to 1.01 in the overall cohort for the SCA2, SCA3, SCA6, and SCA17 loci.CONCLUSIONS: Our study did not support a major role for definite pathogenic repeat expansions in SCA2, SCA3, SCA6, and SCA17 genes for idiopathic PD. Thus, results of this large study do not support diagnostic screening of SCA2, SCA3, SCA6, and SCA17 gene repeats in the common idiopathic form of PD. Likewise, this largest multicentered study performed to date excludes the role of intermediate repeats of these genes as a risk factor for PD.",

author = "Lisa Wang and Aasly, \{Jan O\} and Grazia Annesi and Soraya Bardien and Maria Bozi and Alexis Brice and Jonathan Carr and Chung, \{Sun J\} and Carl Clarke and David Crosiers and Angela Deutschl{\"a}nder and Gertrud Eckstein and Farrer, \{Matthew J\} and Stefano Goldwurm and Gaetan Garraux and Hadjigeorgiou, \{Georgios M\} and Hicks, \{Andrew A\} and Nobutaka Hattori and Christine Klein and Beom Jeon and Kim, \{Yun J\} and Suzanne Lesage and Juei-Jueng Lin and Timothy Lynch and Peter Lichtner and Lang, \{Anthony E\} and Vincent Mok and Barbara Jasinska-Myga and Mellick, \{George D\} and Morrison, \{Karen E\} and Grzegorz Opala and Lasse Pihlstr{\o}m and Pramstaller, \{Peter P\} and Park, \{Sung S\} and Aldo Quattrone and Ekaterina Rogaeva and Ross, \{Owen A\} and Leonidas Stefanis and Stockton, \{Joanne D\} and Silburn, \{Peter A\} and Jessie Theuns and Tan, \{Eng K\} and Hiroyuki Tomiyama and Mathias Toft and \{Van Broeckhoven\}, Christine and Uitti, \{Ryan J\} and Karin Wirdefeldt and Zbigniew Wszolek and Georgia Xiromerisiou and Kuo-Chu Yueh and \{Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium\}",

note = "{\textcopyright} 2015 American Academy of Neurology.",

year = "2015",

month = oct,

day = "13",

doi = "10.1212/WNL.0000000000002016",

language = "English",

volume = "85",

pages = "1283--1292",

journal = "Neurology",

issn = "0028-3878",

publisher = "American Academy of Neurology",

}

Wang, L, Aasly, JO, Annesi, G, Bardien, S, Bozi, M, Brice, A, Carr, J, Chung, SJ, Clarke, C, Crosiers, D, Deutschländer, A, Eckstein, G, Farrer, MJ, Goldwurm, S, Garraux, G, Hadjigeorgiou, GM, Hicks, AA, Hattori, N, Klein, C, Jeon, B, Kim, YJ, Lesage, S, Lin, J-J, Lynch, T, Lichtner, P, Lang, AE, Mok, V, Jasinska-Myga, B, Mellick, GD, Morrison, KE, Opala, G, Pihlstrøm, L, Pramstaller, PP, Park, SS, Quattrone, A, Rogaeva, E, Ross, OA, Stefanis, L, Stockton, JD, Silburn, PA, Theuns, J, Tan, EK, Tomiyama, H, Toft, M, Van Broeckhoven, C, Uitti, RJ, Wirdefeldt, K, Wszolek, Z, Xiromerisiou, G, Yueh, K-C & Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium 2015, 'Large-scale assessment of polyglutamine repeat expansions in Parkinson disease', Neurology, vol. 85, pp. 1283-1292. https://doi.org/10.1212/WNL.0000000000002016

TY - JOUR

T1 - Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

AU - Wang, Lisa

AU - Aasly, Jan O

AU - Annesi, Grazia

AU - Bardien, Soraya

AU - Bozi, Maria

AU - Brice, Alexis

AU - Carr, Jonathan

AU - Chung, Sun J

AU - Clarke, Carl

AU - Crosiers, David

AU - Deutschländer, Angela

AU - Eckstein, Gertrud

AU - Farrer, Matthew J

AU - Goldwurm, Stefano

AU - Garraux, Gaetan

AU - Hadjigeorgiou, Georgios M

AU - Hicks, Andrew A

AU - Hattori, Nobutaka

AU - Klein, Christine

AU - Jeon, Beom

AU - Kim, Yun J

AU - Lesage, Suzanne

AU - Lin, Juei-Jueng

AU - Lynch, Timothy

AU - Lichtner, Peter

AU - Lang, Anthony E

AU - Mok, Vincent

AU - Jasinska-Myga, Barbara

AU - Mellick, George D

AU - Morrison, Karen E

AU - Opala, Grzegorz

AU - Pihlstrøm, Lasse

AU - Pramstaller, Peter P

AU - Park, Sung S

AU - Quattrone, Aldo

AU - Rogaeva, Ekaterina

AU - Ross, Owen A

AU - Stefanis, Leonidas

AU - Stockton, Joanne D

AU - Silburn, Peter A

AU - Theuns, Jessie

AU - Tan, Eng K

AU - Tomiyama, Hiroyuki

AU - Toft, Mathias

AU - Van Broeckhoven, Christine

AU - Uitti, Ryan J

AU - Wirdefeldt, Karin

AU - Wszolek, Zbigniew

AU - Xiromerisiou, Georgia

AU - Yueh, Kuo-Chu

AU - Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium

PY - 2015/10/13

Y1 - 2015/10/13

N2 - OBJECTIVES: We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).METHODS: We invited researchers from the Genetic Epidemiology of Parkinson's Disease Consortium to participate in the study. There were 12,346 cases and 8,164 controls genotyped, for a total of 4 repeats within the SCA2, SCA3, SCA6, and SCA17 genes. Fixed- and random-effects models were used to estimate the summary risk estimates for the genes. We investigated between-study heterogeneity and heterogeneity between different ethnic populations.RESULTS: We did not observe any definite pathogenic repeat expansions for SCA2, SCA3, SCA6, and SCA17 genes in patients with idiopathic PD from Caucasian and Asian populations. Furthermore, overall analysis did not reveal any significant association between intermediate repeats and PD. The effect estimates (odds ratio) ranged from 0.93 to 1.01 in the overall cohort for the SCA2, SCA3, SCA6, and SCA17 loci.CONCLUSIONS: Our study did not support a major role for definite pathogenic repeat expansions in SCA2, SCA3, SCA6, and SCA17 genes for idiopathic PD. Thus, results of this large study do not support diagnostic screening of SCA2, SCA3, SCA6, and SCA17 gene repeats in the common idiopathic form of PD. Likewise, this largest multicentered study performed to date excludes the role of intermediate repeats of these genes as a risk factor for PD.

AB - OBJECTIVES: We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).METHODS: We invited researchers from the Genetic Epidemiology of Parkinson's Disease Consortium to participate in the study. There were 12,346 cases and 8,164 controls genotyped, for a total of 4 repeats within the SCA2, SCA3, SCA6, and SCA17 genes. Fixed- and random-effects models were used to estimate the summary risk estimates for the genes. We investigated between-study heterogeneity and heterogeneity between different ethnic populations.RESULTS: We did not observe any definite pathogenic repeat expansions for SCA2, SCA3, SCA6, and SCA17 genes in patients with idiopathic PD from Caucasian and Asian populations. Furthermore, overall analysis did not reveal any significant association between intermediate repeats and PD. The effect estimates (odds ratio) ranged from 0.93 to 1.01 in the overall cohort for the SCA2, SCA3, SCA6, and SCA17 loci.CONCLUSIONS: Our study did not support a major role for definite pathogenic repeat expansions in SCA2, SCA3, SCA6, and SCA17 genes for idiopathic PD. Thus, results of this large study do not support diagnostic screening of SCA2, SCA3, SCA6, and SCA17 gene repeats in the common idiopathic form of PD. Likewise, this largest multicentered study performed to date excludes the role of intermediate repeats of these genes as a risk factor for PD.

UR - https://www.scopus.com/pages/publications/84944415009

U2 - 10.1212/WNL.0000000000002016

DO - 10.1212/WNL.0000000000002016

M3 - Article

C2 - 26354989

SN - 0028-3878

VL - 85

SP - 1283

EP - 1292

JO - Neurology

JF - Neurology

ER -

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this